Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
11 Jul 2024
Researchers Identify Biomarker for Recurrence in Renal Cell Carcinoma
A new study has developed and validated a 15-gene expression-based biomarker that could facilitate risk stratification for clear cell renal cell carcinoma.
11 Jul 2024
Early-Stage Prostate Cancer May Be Missed in Transgender Women
Prostate-specific antigen screening may miss early-stage prostate cancer in transgender women undergoing oestrogen therapy, according to new research.
9 Jul 2024
Women in Europe Are Receiving More Cycles of IVF: ESHRE 2024
Uptake of in vitro fertilisation and intrauterine insemination has increased among women in Europe, according to data presented at the ESHRE 40th annual meeting.
9 Jul 2024
Socioeconomic Status Affects Fertility Treatment Outcomes: ESHRE 2024
New research presented at ESHRE highlights significant social disparities in achieving live births following assisted reproductive technology treatment.
8 Jul 2024
Gestational Carriers Face Higher Health Risks: ESHRE 2024
Research presented at ESHRE 2024 reveals higher risks of severe maternal morbidity and adverse pregnancy outcomes for gestational carriers compared to natural and IVF conceptions.
8 Jul 2024
Air Pollution Linked to Decreased IVF Success: ESHRE 2024
Pioneering research presented at the ESHRE 40th Annual Meeting suggests that exposure to fine particulate matter before the retrieval of oocytes during IVF can impact the odds of achieving a life birth.
5 Jul 2024
Benefits of Intensity Modulated Radiotherapy for Advanced Lung Cancer
New findings have provided crucial insights into the optimal radiotherapy techniques for treating unresectable locally advanced non–small cell lung cancer.
5 Jul 2024
Ultrasonography Unreliable for Diagnosing Endometrial Cancer in Black Females
Concerns about the reliability of transvaginal ultrasonography in diagnosing endometrial cancer among Black females have been raised in a recent study.
3 Jul 2024
Proton-Pump Inhibitors Prevent Stress Ulcers During Invasive Ventilation
Novel research has shed light on the efficacy of proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients undergoing invasive ventilation.
3 Jul 2024
Researchers Identify Presenting Symptoms in Early-Onset Colorectal Cancer
Hematochezia and abdominal pain are the initial symptoms in nearly half of individuals with early-onset colorectal cancer, according to recent research.
←
1
2
3
…
53
54
55
56
57
58
59
…
63
64
65
→
We’ve noticed you’re accessing
from
North/South America.
View
View